Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

794
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
794
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

118
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
118
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

65
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
65
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

813
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
813
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

139
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel approach for enhancing the potency of kinase inhibitors using topological water networks.

Journal of cheminformatics·2026
Same author

Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses isolated from felines in South Korea, 2023.

Virulence·2026
Same author

Corrigendum to "E1K, a disease-modifying drug candidate for knee osteoarthritis, alleviates pain and regenerates cartilage simultaneously by inhibiting TGF-β1-mediated SMAD1/5/9 signaling in osteoarthritis models" [Osteoarthr. Cartil. 34 (2) (2026) 240-250].

Osteoarthritis and cartilage·2026
Same author

The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Ovarian Serous Cystadenocarcinoma.

Reproductive sciences (Thousand Oaks, Calif.)·2026
Same author

Pyrazole-Based Transthyretin Kinetic Stabilizers Identified Using a Covalent Fluorescent Probe Assay for Selectivity Profiling in Human Serum.

Journal of medicinal chemistry·2025
Same author

E1K, a disease-modifying drug candidate for knee osteoarthritis, alleviates pain and regenerates cartilage simultaneously by inhibiting TGF-β1-mediated SMAD1/5/9 signaling in osteoarthritis models.

Osteoarthritis and cartilage·2025

Related Experiment Video

Updated: Jul 25, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

ADis-QSAR: a machine learning model based on biological activity differences of compounds.

Gyoung Jin Park1, Nam Sook Kang2

  • 1Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehak-ro,Yuseong-gu, Daejeon, 34134, Korea.

Journal of Computer-Aided Molecular Design
|June 29, 2023
PubMed
Summary

A new Activity Differences-Quantitative Structure-Activity Relationship (ADis-QSAR) model enhances drug discovery by creating molecular descriptors that better capture compound activity differences. This approach improves prediction accuracy and reduces false positives.

Keywords:
Machine learningMolecular fingerprintQSARVirtual screening

More Related Videos

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.1K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K

Related Experiment Videos

Last Updated: Jul 25, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K
Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.1K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K

Area of Science:

  • * Cheminformatics
  • * Computational Chemistry
  • * Drug Discovery

Background:

  • * Pharmaceutical drug development relies on identifying compounds with specific structural characteristics for target interaction.
  • * Quantitative Structure-Activity Relationship (QSAR) analysis is crucial for predicting compound activity and improving drug development efficiency.
  • * Existing QSAR models face challenges in effectively representing the differences between active and inactive compound groups.

Purpose of the Study:

  • * To develop a novel ADis-QSAR model using molecular descriptors that explicitly highlight activity differences between compound groups.
  • * To improve the predictive power of QSAR models for more efficient and cost-effective drug development.
  • * To reduce the selection of false positive compounds in early-stage drug discovery.

Main Methods:

  • * Generation of novel molecular descriptors designed to capture pairwise differences between active and inactive compounds.
  • * Implementation and comparison of machine learning algorithms including Support Vector Machine (SVM), Random Forest, XGBoost, and Multi-Layer Perceptron.
  • * Evaluation of model performance using metrics such as accuracy, area under the curve (AUC), precision, and specificity.

Main Results:

  • * The ADis-QSAR model demonstrated significant improvements in precision and specificity compared to baseline models.
  • * Support Vector Machine (SVM) algorithm yielded the best performance among the tested machine learning models.
  • * The ADis-QSAR model proved effective even on datasets with dissimilar chemical spaces, indicating robustness.

Conclusions:

  • * The developed ADis-QSAR model offers a more effective approach to representing structural differences crucial for drug activity.
  • * This enhanced model can significantly reduce the risk of false positives, thereby streamlining the drug development pipeline.
  • * ADis-QSAR represents a valuable advancement in computational chemistry for optimizing drug candidate selection.